Charles Schwab Investment Management Inc. Increases Position in Houlihan Lokey, Inc. (NYSE:HLI)

Charles Schwab Investment Management Inc. raised its position in Houlihan Lokey, Inc. (NYSE:HLI - Free Report) by 33.0% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 601,025 shares of the financial services provider's stock after buying an additional 149,114 shares during the period. Charles Schwab Investment Management Inc. owned about 0.86% of Houlihan Lokey worth $94,974,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of HLI. Lazard Asset Management LLC acquired a new stake in Houlihan Lokey in the 1st quarter worth about $127,000. Price T Rowe Associates Inc. MD lifted its stake in Houlihan Lokey by 6.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 26,709 shares of the financial services provider's stock worth $3,424,000 after purchasing an additional 1,631 shares in the last quarter. Janus Henderson Group PLC lifted its stake in Houlihan Lokey by 27.1% in the 1st quarter. Janus Henderson Group PLC now owns 30,656 shares of the financial services provider's stock worth $3,927,000 after purchasing an additional 6,535 shares in the last quarter. Tidal Investments LLC raised its position in shares of Houlihan Lokey by 201.5% during the 1st quarter. Tidal Investments LLC now owns 11,093 shares of the financial services provider's stock valued at $1,422,000 after buying an additional 7,414 shares during the period. Finally, Cetera Investment Advisers raised its position in shares of Houlihan Lokey by 604.4% during the 1st quarter. Cetera Investment Advisers now owns 13,525 shares of the financial services provider's stock valued at $1,734,000 after buying an additional 11,605 shares during the period. 78.07% of the stock is currently owned by institutional investors and hedge funds.

Houlihan Lokey Stock Down 0.2 %

Shares of NYSE HLI opened at $190.08 on Wednesday. The firm has a market cap of $13.21 billion, a price-to-earnings ratio of 38.87 and a beta of 0.65. Houlihan Lokey, Inc. has a 52-week low of $104.86 and a 52-week high of $192.10. The business's 50 day moving average is $170.99 and its two-hundred day moving average is $152.11.

Houlihan Lokey (NYSE:HLI - Get Free Report) last posted its quarterly earnings results on Wednesday, October 30th. The financial services provider reported $1.46 EPS for the quarter, topping the consensus estimate of $1.31 by $0.15. The business had revenue of $574.96 million during the quarter, compared to the consensus estimate of $537.93 million. Houlihan Lokey had a net margin of 15.77% and a return on equity of 19.29%. The company's quarterly revenue was up 23.1% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.11 earnings per share. Analysts anticipate that Houlihan Lokey, Inc. will post 5.79 EPS for the current fiscal year.

Houlihan Lokey Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Sunday, December 15th. Shareholders of record on Monday, December 2nd will be paid a $0.57 dividend. The ex-dividend date of this dividend is Monday, December 2nd. This represents a $2.28 annualized dividend and a dividend yield of 1.20%. Houlihan Lokey's dividend payout ratio (DPR) is 46.63%.

Analyst Ratings Changes

HLI has been the topic of several analyst reports. JPMorgan Chase & Co. reduced their price target on shares of Houlihan Lokey from $132.00 to $129.00 and set a "neutral" rating on the stock in a research report on Wednesday, July 31st. Keefe, Bruyette & Woods reaffirmed a "market perform" rating and set a $154.00 price target (up previously from $139.00) on shares of Houlihan Lokey in a research report on Wednesday, July 31st. UBS Group lifted their price target on shares of Houlihan Lokey from $170.00 to $190.00 and gave the company a "buy" rating in a research report on Tuesday, October 8th. Morgan Stanley lifted their price target on shares of Houlihan Lokey from $146.00 to $163.00 and gave the company an "equal weight" rating in a research report on Monday, September 23rd. Finally, StockNews.com lowered Houlihan Lokey from a "buy" rating to a "hold" rating in a research report on Wednesday, November 20th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Houlihan Lokey currently has an average rating of "Hold" and a consensus price target of $157.00.

Insiders Place Their Bets

In related news, Director Gillian Beth Zucker sold 200 shares of the business's stock in a transaction on Monday, October 14th. The shares were sold at an average price of $168.08, for a total transaction of $33,616.00. Following the completion of the transaction, the director now owns 6,601 shares in the company, valued at approximately $1,109,496.08. The trade was a 2.94 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, General Counsel Christopher M. Crain sold 1,000 shares of the business's stock in a transaction on Tuesday, September 3rd. The stock was sold at an average price of $155.29, for a total transaction of $155,290.00. The disclosure for this sale can be found here. Insiders sold a total of 1,400 shares of company stock worth $219,362 over the last 90 days. Corporate insiders own 23.68% of the company's stock.

Houlihan Lokey Company Profile

Houlihan Lokey, Inc, an investment banking company, provides merger and acquisition (M&A), capital market, financial restructuring, and financial and valuation advisory services worldwide. It operates in three segments: Corporate Finance, Financial Restructuring, and Financial and Valuation Advisory.